Metraipolis › archive › dc_fc49054ec944

Efficacy and Safety of Avatrombopag in Patients with Chronic Liver Disease and Thrombocytopenia Undergoing Elective Surgery — Europe PMC PMID:42513628

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42513628
DOI
10.3390/jcm15145715
License (as archived)
solo-consultazione
Archived
2026-10-18T02:25:15.163Z
SHA-256 of the archived text
cee19c999eaf413eab0427f5b25fdb156176660b5fcfdc09a51ff468d6647ce2
Stable URL of this page
https://metraipolis.com/documento/dc_fc49054ec944

How to cite

Efficacy and Safety of Avatrombopag in Patients with Chronic Liver Disease and Thrombocytopenia Undergoing Elective Surgery — Europe PMC PMID:42513628 — Europe PMC (en), https://europepmc.org/article/MED/42513628 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fc49054ec944 (Metraipolis archive dc_fc49054ec944, sha256 cee19c999eaf413eab0427f5b25fdb156176660b5fcfdc09a51ff468d6647ce2)
BibTeX
@misc{dcfc49054ec944,
  title = {Efficacy and Safety of Avatrombopag in Patients with Chronic Liver Disease and Thrombocytopenia Undergoing Elective Surgery — Europe PMC PMID:42513628},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42513628},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fc49054ec944; sha256 cee19c999eaf413eab0427f5b25fdb156176660b5fcfdc09a51ff468d6647ce2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42513628. Agents can read the archived copy with the MCP tool read_document.